BridgeMD
New treatment option for Retinopathy of Prematurity (ROP)
Official title The Effect of Two Non-Pharmacological Methods on Pain During Retinopathy Examination
ClinicalTrials.gov ID: NCT06694103
What this study is testing
- What it's testing
- The goal of this randomized controlled trial is to determine the effect of reverse kangaroo care position and ROP (Retinopathy of Prematurity) position applied during ROP examination in premature infants on pain. The main questions it aims to answer are as follows: 1.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 28 to 33. Healthy volunteers may be eligible.
You may be able to join if
- Gestational age \<34 weeks,
- Birth weight ≤ 2500 grams,
- No painful interventions at least 1 hour before the ROP examination,
- Fed at least 1 hour before the ROP examination,
- Premature infants whose parents consented to participate in the study.
You likely can't join if
- Having a condition that prevents pain assessment (intracranial hemorrhage, neuromotor developmental delay etc.)
- Any congenital anomaly (eye, neurological, etc.),
- Have a diagnosed hearing problem,
- A different painful procedure was performed at least one hour before the ROP examination,
- Administration of an analgesic/sedative medication before the examination,
- Premature infants whose parents did not consent to participate in the study.
The study team makes the final eligibility decision.
Where it's taking place
- Izmir, Menemen, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 28 weeks to 33 weeks. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Izmir, Menemen, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.